Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1658 1676
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18227540 | GDF11 VARIANTS AND USES THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 18297593 | RECOMBINANTLY ENGINEERED POLYPEPTIDES CAPABLE OF RECYCLING NONCANONICAL COFACTORS | Non-Final OA | The Regents of the University of California |
| 17624824 | MULTISPECIFIC TRANSTHYRETIN IMMUNOGLOBULIN FUSIONS | Non-Final OA | AMGEN INC. |
| 18783546 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Non-Final OA | Mallinckrodt Pharmaceuticals Ireland Limited |
| 17976606 | METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME | Final Rejection | Mallinckrodt Pharmaceuticals Ireland Limited |
| 17587442 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Final Rejection | Mallinckrodt Pharmaceuticals Ireland Limited |
| 17793369 | PEGYLATED IGE-DEPENDENT HISTAMINE-RELEASING FACTOR (HRF)-BINDING PEPTIDE AND USE THEREOF | Final Rejection | EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION |
| 19018888 | iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS | Non-Final OA | LISATA THERAPEUTICS, INC. |
| 17233022 | BULLFROG SKIN-DERIVED COLLAGEN, MATERIALS COMPRISING THEREOF, AND APPLICATIONS IN WOUND HEALING | Non-Final OA | Nanyang Technological University |
| 18238261 | COMPOSITIONS AND METHODS FOR TREATING TYPE 2 DIABETES USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
| 18815249 | REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS | Final Rejection | OREGON STATE UNIVERSITY |
| 18434318 | CONJUGATED VACCINE CARRIER PROTEINS | Non-Final OA | Vaxcyte, Inc. |
| 18257165 | CELL PENETRATING PEPTIDE MEDIATED RNA TRANSDUCTION WITHIN INSECT CELLS | Non-Final OA | PIONEER HI-BRED INTERNATIONAL, INC. |
| 18281147 | AFFINITY AGENTS | Non-Final OA | Avitide LLC |
| 17198285 | PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF | Final Rejection | UNIVERSITE DE GENEVE |
| 18259752 | VEGF-REGULATING PEPTIDES | Non-Final OA | IDP DISCOVERY PHARMA, S.L. |
| 18128465 | METHODS OF USING ACTIVIN RECEPTOR TYPE II VARIANTS | Non-Final OA | Keros Therapeutics, Inc. |
| 18170979 | HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE | Final Rejection | Quthero, Inc. |
| 16963578 | USE OF CYCLIC PEPTIDES IN COSMETIC | Non-Final OA | Sederma |
| 16337730 | NOVEL FORMULATIONS | Non-Final OA | Arecor Limited |
| 17767056 | A composition for boosting the immune system | Non-Final OA | MAOLAC LTD. |
| 17712752 | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS | Non-Final OA | RHYTHM PHARMACEUTICALS, INC. |
| 15764730 | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS | Non-Final OA | RHYTHM PHARMACEUTICALS, INC. |
| 17693478 | TREATMENT FOR TUMORS DRIVEN BY METABOLIC DYSFUCTION | Final Rejection | SynDevRx, Inc. |
| 17612038 | USE OF COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING BONE LOSS DISORDERS, COMPRISING CYCLO-HISPRO (CHP) AND PARATHYROID HORMONE | Final Rejection | NOVMETAPHARMA CO., LTD. |
| 17606124 | AGING PROGRESSION SUPPRESSING AGENT, AND FOOD OR BEVERAGE PRODUCT COMPRISING SAME | Final Rejection | NITTA GELATIN INC. |
| 17493546 | LIPID COMPOSITIONS WITH HIGH DHA CONTENT | Non-Final OA | ARCTIC BIOSCIENCE AS |
| 17294570 | COMBINATION OF CHEMOTHERAPY WITH RECOMBINANT S. ROLFSII LECTIN | Non-Final OA | Unichem Laboratories Ltd |
| 17104864 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Final Rejection | Mallinckrodt Hospital Products IP Unlimited Company |
| 17080300 | PEPTIDE-MEDIATED INTRAVESICAL DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS | Final Rejection | THE UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy